InvestorsHub Logo
Followers 4
Posts 388
Boards Moderated 0
Alias Born 10/28/2013

Re: ziploc_1 post# 337953

Saturday, 05/01/2021 5:12:52 AM

Saturday, May 01, 2021 5:12:52 AM

Post# of 426330
Agree.

My fairly optimistic read of the situation is that we can probably maintain between $500-$1B annual sales in Vascepa over the next 5 years.

Not a lot for sure and a far cry from projections post approval

But still roughly $1B in free cash flow assuming EU operations cover HQ overheads (roughly 20% net margins after us sg&a)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News